No results for ‘’
Windlas Biotech Ltd
₹829.45
(0.71%)
Wed, 17 Jun 2026, 02:25 am
Health Technology
Pharmaceuticals: Major
24.5KWindlas Biotech Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 61.90 | 61.99 | 61.99 | 62.34 | 62.34 |
| FII | 0.60 | 0.93 | 1.11 | 1.44 | 1.52 |
| DII | 11.81 | 11.44 | 11.43 | 11.21 | 10.89 |
| Public | 25.70 | 25.64 | 25.47 | 25.01 | 25.25 |
| Government | 0 | 0 | 0 | 0 | 0 |
Windlas Biotech Ltd Shareholding Pattern
The Windlas Biotech Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Windlas Biotech Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Windlas Biotech Ltd (NSE: WINDLAS, BSE: 543329) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Windlas Biotech Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Windlas Biotech Ltd Shareholding Pattern (Latest)
The latest Windlas Biotech Ltd shareholding for Mar 2026 is:
- Promoters: 61.90%
- FII: 0.60%
- DII: 11.81%
- Public: 25.70%
- Government: 0%
A slight decline in promoter holding may indicate stake dilution or strategic selling.
Windlas Biotech Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Windlas Biotech Ltd.
- Mar 2026: 61.90%
- Dec 2025: 61.99%
- Sept 2025: 61.99%
- Jun 2025: 62.34%
- Mar 2025: 62.34%
Promoter stake remains largely stable, showing consistent ownership structure.
Windlas Biotech Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Windlas Biotech Ltd.
- Mar 2026: 0.60%
- Dec 2025: 0.93%
- Sept 2025: 1.11%
- Jun 2025: 1.44%
- Mar 2025: 1.52%
FII holding has declined, suggesting cautious sentiment among foreign investors.
Windlas Biotech Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Mar 2026: 11.81%
- Dec 2025: 11.44%
- Sept 2025: 11.43%
- Jun 2025: 11.21%
- Mar 2025: 10.89%
DII stake in Windlas Biotech Ltd has increased over time, indicating growing domestic institutional confidence.
Windlas Biotech Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Mar 2026: 25.70%
- Dec 2025: 25.64%
- Sept 2025: 25.47%
- Jun 2025: 25.01%
- Mar 2025: 25.25%
Public participation in Windlas Biotech Ltd has increased, indicating rising retail investor interest.
Windlas Biotech Ltd Government Holding
Government holding in Windlas Biotech Ltd currently stands at 0%.
Windlas Biotech Ltd operates without significant government ownership.
Windlas Biotech Ltd Shareholding Analysis Summary
The Windlas Biotech Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Windlas Biotech Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.
Regular monitoring of the Windlas Biotech Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.